Microfluidic Droplet Monolayer Imaging for Nucleic Acid Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current assay systems, such as PCR for nucleic acids, are slow, sensitive to sample complexity, and prone to false positives, necessitating improved methods for rapid and accurate analysis of minor sample constituents.
Innovation Solution
A microfluidic device with a flow path for sample analysis, where samples are partitioned into droplets, imaged in a two-dimensional monolayer, and subjected to droplet-based assays for nucleic acid analysis, including droplet generation, reaction, and detection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional PCR assays are used for nucleic acid analysis, then the analysis can be performed with standard equipment, but the assay time is long and the system is slow
Solution Approach 1:
The patent segments the sample into numerous individual droplets, each containing a tiny volume of the original sample. This segmentation enables parallel processing of many samples simultaneously in a single run, dramatically increasing productivity while reducing the time required per sample. The droplet format allows thousands of reactions to occur concurrently rather than sequentially.
Solution Approach 2:
The patent transitions from traditional two-dimensional gel electrophoresis to three-dimensional droplet-based analysis. By suspending droplets in three-dimensional space within a flow cell, the system can image and analyze many more droplets simultaneously compared to flat 2D gels, thereby increasing throughput and reducing assay time.
2Reliability
If traditional assay systems are used, then the equipment is simple and easy to operate, but the system is sensitive to sample complexity and prone to false positives
Solution Approach 1:
By partitioning the sample into individual droplets, the system isolates each reaction in space, preventing cross-contamination and reducing false positives. Each droplet acts as an independent reaction chamber, allowing for more reliable detection of target molecules even in complex samples with many interfering substances.
Solution Approach 2:
The patent applies different properties to different parts of the system: droplets contain the sample and reagents for specific chemical reactions, while the surrounding oil phase provides isolation and stability. The flow cell geometry and imaging system are optimized locally for detecting signals from individual droplets, enhancing overall reliability without requiring complete system redesign.
3Measurement precision
If samples are analyzed in bulk, then the analysis covers the entire sample, but background noise is high and sensitivity to minor constituents is reduced
Solution Approach 1:
Segmenting the bulk sample into individual droplets physically separates the signal from the background noise. Each droplet contains a discrete amount of sample, allowing detection of rare or minor constituents without interference from the complex bulk matrix. The oil phase surrounding each droplet provides an acoustically and optically favorable environment that reduces background noise.
Solution Approach 2:
The patent extracts the sample from the bulk liquid matrix by partitioning it into discrete droplets suspended in oil. This extraction removes interfering substances from the immediate detection environment, isolating the analyte of interest in a controlled microenvironment where background noise is minimized and detection sensitivity is enhanced.
Data Source
AI summary
Method of analysis. In the method, a microfluidic device defining a flow path extending from an inlet to an outlet may be selected. A sample-containing fluid may be introduced into the flow path via the inlet. Volumes of the sample-containing fluid may be isolated from one another on the flow path. A two-dimensional monolayer of the volumes may be imaged. The two-dimensional monolayer may be formed along the flow path between the inlet and the outlet.